One Man’s Quest to Treat Brain Diseases
Prof. Moussa Youdim, a pioneer in the treatment of Parkinson's disease, has added another feather to his cap. In November, he was awarded the EMET Prize, just as his anti-Alzheimer’s drug Ladostigil entered Phase II clinical trials in Europe.
Read more about Prof. Youdim's honor.
Don't miss your opportunity to meet Prof. Youdim, as he will be speaking at locations across the U.S. in January and February. Please contact your regional director for more information.